Edgar Lomax Co. VA Sells 13,615 Shares of CVS Health Co. (NYSE:CVS)

Edgar Lomax Co. VA lessened its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 1.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 886,830 shares of the pharmacy operator's stock after selling 13,615 shares during the period. CVS Health makes up approximately 2.6% of Edgar Lomax Co. VA's holdings, making the stock its 14th largest position. Edgar Lomax Co. VA owned 0.07% of CVS Health worth $39,810,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CVS. Dodge & Cox lifted its position in CVS Health by 11.2% in the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after purchasing an additional 7,075,209 shares during the period. Geode Capital Management LLC increased its stake in CVS Health by 2.6% in the fourth quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator's stock valued at $1,211,582,000 after acquiring an additional 689,867 shares during the period. Capital International Investors boosted its holdings in CVS Health by 4.8% during the fourth quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock valued at $1,196,989,000 after purchasing an additional 1,212,126 shares in the last quarter. Pzena Investment Management LLC grew its position in CVS Health by 49.3% in the fourth quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock valued at $880,319,000 after acquiring an additional 6,475,271 shares during the period. Finally, Norges Bank acquired a new position in CVS Health during the fourth quarter worth $839,574,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on CVS shares. Piper Sandler upped their price objective on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research note on Friday, March 21st. Leerink Partnrs raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. Barclays boosted their price objective on shares of CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. boosted their price objective on CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a report on Tuesday, February 18th. Finally, Cantor Fitzgerald upgraded CVS Health from a "neutral" rating to an "overweight" rating in a report on Wednesday, February 12th. Four research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $71.83.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney bought 30,000 shares of CVS Health stock in a transaction dated Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.22% of the stock is currently owned by insiders.

CVS Health Stock Up 0.2 %

CVS traded up $0.13 during trading on Wednesday, reaching $65.58. 10,463,537 shares of the stock were exchanged, compared to its average volume of 11,827,130. The stock has a market cap of $82.68 billion, a P/E ratio of 17.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The stock's 50 day moving average price is $66.48 and its two-hundred day moving average price is $58.77. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $71.45.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.06%. CVS Health's dividend payout ratio (DPR) is presently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.